{"id":864600,"date":"2025-06-27T09:52:24","date_gmt":"2025-06-27T13:52:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/"},"modified":"2025-06-27T09:52:24","modified_gmt":"2025-06-27T13:52:24","slug":"reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/","title":{"rendered":"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">IRVINE, Calif., June  27, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=INUyhwemsbRCdF2IRIt7GNPq7yFrb4aqSIhxFtemzFbBUbu4F5xYa3WjyY-3MCkDFZc7J_cLWeyUgJsxceLRmkoFTISFo2Ad1mZrqnVNUaCR-sCu9hF9E06uQxt7pEKs\" rel=\"nofollow\" target=\"_blank\"><strong>ReShape Lifesciences Inc.<\/strong><\/a><strong> (Nasdaq: RSLS), <\/strong>the premier physician-led weight loss and metabolic health-solutions company, today announced that on June 23, 2025, it received formal notice from The Nasdaq Stock Market, LLC (\u201cNasdaq\u201d) indicating that the Company has regained compliance with Nasdaq&#8217;s stockholders equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) and otherwise satisfies all other applicable criteria for continued listing on The Nasdaq Capital Market. As a result, the listing matter has been closed.<\/p>\n<p align=\"justify\">On May 28, 2025, Nasdaq notified the Company that its securities were subject to delisting from Nasdaq based on the Company\u2019s continued non-compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2.5 million in stockholders\u2019 equity for continued listing.<\/p>\n<p align=\"justify\">As of March 31, 2025, the Company\u2019s stockholders\u2019 equity was $1.2 million. However (a) between June 3, 2025 and June 6, 2025, the Company sold 593,000 shares of common stock for gross proceeds of $3,642,564 pursuant to an equity distribution agreement with Maxim Group LLC in an \u201cat-the-market\u201d offering, as previously disclosed in the Company\u2019s prospectus supplement filed with the Securities and Exchange Commission (\u201cSEC\u201d) on June 9, 2025 and (b) on June 9, 2025, the Company completed an offering of 1,054,604 shares of common stock for gross proceeds of $2,636,510, as previously disclosed in the Company\u2019s Form 8-K filed with the SEC on June 12, 2025.<\/p>\n<p align=\"justify\">\n        <strong>About ReShape Lifesciences\u00ae <\/strong><br \/>\n        <br \/>ReShape Lifesciences\u00ae is America\u2019s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band\u00ae System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The investigational vagal neuromodulation system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of type 2 diabetes and metabolic disorders. The Obalon\u00ae balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mJaQL9jme-Gz_ImKAvAkzjxx_Jx31CotWu-vpm-udX5xZe3yxrTurjE88rAeUO-rd4fPDiE3z1TcngJiRLb9f0SpHc2CD0-83W_gEFg9ZiIzpEuHY_npdGsxj1yzpOGw\" rel=\"nofollow\" target=\"_blank\">www.reshapelifesciences.com<\/a>.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>ReShape Lifesciences Contact:<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Paul F. Hickey<br \/>President and Chief Executive Officer<br \/>949-276-7223<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xesKndgAC0WYsfeRf0ezGYajsNbEzQWyT5hmLuYSrHaqtM4eNwiTIrw-jVPNG1spffR88zg6N7Rs2NvQ3lH2j1OQfy6_3DZs_XJx2420VVo=\" rel=\"nofollow\" target=\"_blank\">ir@ReShapeLifesci.com<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-k9WCaNH-SjIkZfuT_Fkzmq4yNzeavppqBtXcXIRB8dk5_GUhDCHV9pX3djYh3eUzuM8bTii3mo3gBIL0Ri7il7-7Fsx_0Pfp0N3n45Nryo=\" rel=\"nofollow\" target=\"_blank\">Rx Communications Group<\/a><br \/>\n        <br \/>Michael Miller<br \/>(917)-633-6086<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jlXEPwTWrfxAZfPmr1tL_emvQtXfL7Mcemlj9DEf1sJDm8nIe9br4lVNLHTipGNxkhVGamVg6FkvBq4ApYVk4HW1fmeRjSadM1mGKyYsqPg=\" rel=\"nofollow\" target=\"_blank\">mmiller@rxir.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODk2YjBhZDgtYTA0Yy00NTRiLThjOGItZmNiYWJmYzI0NmNhLTEwMTg2NDUtMjAyNS0wNi0yNy1lbg==\/tiny\/ReShape-Lifesciences-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., June 27, 2025 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that on June 23, 2025, it received formal notice from The Nasdaq Stock Market, LLC (\u201cNasdaq\u201d) indicating that the Company has regained compliance with Nasdaq&#8217;s stockholders equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) and otherwise satisfies all other applicable criteria for continued listing on The Nasdaq Capital Market. As a result, the listing matter has been closed. On May 28, 2025, Nasdaq notified the Company that its securities were subject to delisting from Nasdaq based on the Company\u2019s continued non-compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-864600","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., June 27, 2025 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that on June 23, 2025, it received formal notice from The Nasdaq Stock Market, LLC (\u201cNasdaq\u201d) indicating that the Company has regained compliance with Nasdaq&#8217;s stockholders equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) and otherwise satisfies all other applicable criteria for continued listing on The Nasdaq Capital Market. As a result, the listing matter has been closed. On May 28, 2025, Nasdaq notified the Company that its securities were subject to delisting from Nasdaq based on the Company\u2019s continued non-compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market &hellip; Continue reading &quot;ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-27T13:52:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement\",\"datePublished\":\"2025-06-27T13:52:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/\"},\"wordCount\":371,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/\",\"name\":\"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=\",\"datePublished\":\"2025-06-27T13:52:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/","og_locale":"en_US","og_type":"article","og_title":"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - Market Newsdesk","og_description":"IRVINE, Calif., June 27, 2025 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that on June 23, 2025, it received formal notice from The Nasdaq Stock Market, LLC (\u201cNasdaq\u201d) indicating that the Company has regained compliance with Nasdaq&#8217;s stockholders equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) and otherwise satisfies all other applicable criteria for continued listing on The Nasdaq Capital Market. As a result, the listing matter has been closed. On May 28, 2025, Nasdaq notified the Company that its securities were subject to delisting from Nasdaq based on the Company\u2019s continued non-compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market &hellip; Continue reading \"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-27T13:52:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement","datePublished":"2025-06-27T13:52:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/"},"wordCount":371,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/","name":"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=","datePublished":"2025-06-27T13:52:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTYwNCM3MDIxNTE3IzIwMDcwNzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ReShape Lifesciences\u00ae Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/864600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=864600"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/864600\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=864600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=864600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=864600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}